Cosyntropin
Cosyntropin is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Cosyntropin; Generic name: COSYNTROPIN; Drug class: Adrenocorticotropic Hormone [EPC].
| Brand name | Cosyntropin |
|---|---|
| Generic name | COSYNTROPIN |
| Drug class | Adrenocorticotropic Hormone [EPC] |
| Manufacturer | Sandoz Inc |
| Used for | 1 INDICATIONS AND USAGE Cosyntropin for injection is indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients. Cosyntropin for injection is an adrenocorticotropin hormone indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • In general, stop glucocorticoids and spironolactone on the day of cosyntropin for injection testing. For long-acting glucocorticoids, stop for a longer period before cosyntropin for injection testing. ( 2.1 ) • For adults, the recommended dose is 0.25 mg to be administered by intravenous or intramuscular injection. ( 2.2 ) • For pediatric patients, the recommended dose to be administered by intravenous or intramuscular injection is ( 2.3 ): o 0.125 mg for patients b |
| Active ingredient(s) | COSYNTROPIN |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1342169c-e214-4f22-8363-1fd45b85d1e8 |